A detailed history of Steven Cohen (Point72 Asset Management, L.P.) transactions in Ptc Therapeutics, Inc. stock. As of the latest transaction made, Point72 Asset Management, L.P. holds 26,700 shares of PTCT stock, worth $1.15 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
26,700
Previous 26,700 -0.0%
Holding current value
$1.15 Million
Previous $816,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$24.69 - $40.12 $659,223 - $1.07 Million
26,700 New
26,700 $816,000
Q4 2023

Feb 14, 2024

BUY
$18.07 - $29.37 $1.41 Million - $2.29 Million
78,100 New
78,100 $2.15 Million
Q1 2022

May 16, 2022

SELL
$33.33 - $44.6 $11.8 Million - $15.8 Million
-355,100 Closed
0 $0
Q4 2021

Feb 14, 2022

SELL
$35.36 - $41.86 $5.81 Million - $6.88 Million
-164,300 Reduced 31.63%
355,100 $14.1 Million
Q3 2021

Nov 15, 2021

SELL
$37.01 - $44.74 $5.36 Million - $6.47 Million
-144,715 Reduced 21.79%
519,400 $19.3 Million
Q2 2021

Aug 16, 2021

BUY
$37.95 - $49.37 $22.8 Million - $29.7 Million
600,606 Added 945.7%
664,115 $28.1 Million
Q1 2021

May 17, 2021

SELL
$46.8 - $68.92 $41.3 Million - $60.9 Million
-883,491 Reduced 93.29%
63,509 $3.01 Million
Q4 2020

Feb 16, 2021

SELL
$47.96 - $67.64 $7.14 Million - $10.1 Million
-148,829 Reduced 13.58%
947,000 $57.8 Million
Q3 2020

Nov 16, 2020

SELL
$45.41 - $57.07 $9.35 Million - $11.8 Million
-205,945 Reduced 15.82%
1,095,829 $51.2 Million
Q2 2020

Aug 14, 2020

BUY
$42.56 - $54.98 $34.5 Million - $44.6 Million
811,174 Added 165.34%
1,301,774 $66.1 Million
Q1 2020

May 15, 2020

SELL
$32.37 - $59.36 $24.4 Million - $44.8 Million
-755,101 Reduced 60.62%
490,600 $21.9 Million
Q4 2019

Feb 14, 2020

SELL
$32.22 - $50.07 $36.8 Million - $57.2 Million
-1,142,906 Reduced 47.85%
1,245,701 $59.8 Million
Q3 2019

Nov 15, 2019

SELL
$33.82 - $48.17 $8.92 Million - $12.7 Million
-263,840 Reduced 9.95%
2,388,607 $80.8 Million
Q2 2019

Aug 14, 2019

SELL
$35.42 - $45.0 $8.96 Million - $11.4 Million
-252,946 Reduced 8.71%
2,652,447 $119 Million
Q1 2019

May 15, 2019

BUY
$28.09 - $39.49 $40.5 Million - $56.9 Million
1,440,576 Added 98.35%
2,905,393 $109 Million
Q4 2018

Feb 14, 2019

BUY
$29.83 - $46.51 $41 Million - $64 Million
1,375,917 Added 1547.71%
1,464,817 $50.3 Million
Q3 2018

Nov 14, 2018

BUY
$33.9 - $47.77 $3.01 Million - $4.25 Million
88,900 New
88,900 $4.18 Million
Q4 2017

Feb 14, 2018

SELL
$15.14 - $20.89 $6.06 Million - $8.36 Million
-400,000 Closed
0 $0
Q3 2017

Nov 14, 2017

BUY
$16.81 - $21.61 $6.72 Million - $8.64 Million
400,000
400,000 $8 Million

Others Institutions Holding PTCT

About PTC THERAPEUTICS, INC.


  • Ticker PTCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,541,000
  • Market Cap $3.07B
  • Description
  • PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...
More about PTCT
Track Steven Cohen's Portfolio

Track Steven Cohen Portfolio

Follow Steven Cohen (Point72 Asset Management, L.P.) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.